Prolonged Use of Reglan leads to Tardive Dyskinesia


Reglan® (metoclopramide) is a drug used in the treatment of various gastrointestinal problems, including heartburn, nausea and vomiting.

Reglan® and its generic counterpart can be found in tablets, syrups and injectible forms.

In 2009, the FDA required a black box warning to warn users of the dangers of developing tardive dyskinesia. A black box warning is the most serious warning issued by the FDA and signifies that medical studies indicate that the drug carries a significant risk of serious or even life-threatening side effects. The FDA recommends patients be on the medication for no longer than 12 weeks.

Tardive dyskinesia is a permanent, involuntary neurological movement disorder characterized by repetive, involuntary muscle movements frequently affecting the face, eyes, tongue, trunk and extremities. Elderly female patients who have taken Reglan® for an extended period of time are the most at risk for developing tardive dyskinesia, but everyone taking the drug is at risk.

Symptoms of Tardive Dyskinesia

  • Constant movements of the mouth and jaw (almost in a chewing motion)
  • Protuding, squirming tongue
  • Lip smacking
  • Puffing of cheeks
  • Grimacing
  • Rapid Eye blinking
  • Shaking of hands/fingers
  • Shaking of legs/difficulty walking
  • Inability to sit still
  • Rapid movement of the torso
If you or a loved one has developed Tardive Dyskinesia after taking Reglan® please contact attorney Eric Ragatz today for a free consultation. You may be eligible for compensation. Drug manufacturers and doctors have a responsibility to properly warn patients of any serious health risks and side effects associated with prescribed medication.

The law office of Edwards and Ragatz P.A. have experienced product liability attorneys on staff. We have successfully represented clients who have been harmed by defective drugs. Please call us today at (904) 399-1609 to schedule your free consultation.